Marquis DM[Auth] - Search Results

Year	Number of Results
1980	1
1981	2
1984	1
1986	3
1987	1
1990	2
1998	2
1999	1
2002	1
2022	0

1

Current insights into the "antiphospholipid" syndrome: clinical, immunological, and molecular aspects.

Kandiah DA, Sali A, Sheng Y, Victoria EJ, Marquis DM, Coutts SM, Krilis SA. Kandiah DA, et al. Among authors: marquis dm. Adv Immunol. 1998;70:507-63. doi: 10.1016/s0065-2776(08)60393-4. Adv Immunol. 1998. PMID: 9755344 Review.

2

Somatic cell hybridization of human tumor samples.

O'Donnell RW, Leary JF, Penney DP, Budd HS, Marquis DM, Spennacchio JL, Henshaw EC, McCune CS. O'Donnell RW, et al. Among authors: marquis dm. Somat Cell Mol Genet. 1984 Mar;10(2):195-204. doi: 10.1007/BF01534908. Somat Cell Mol Genet. 1984. PMID: 6584990

3

In vivo enhancement of antitumor immunity by interleukin 2-rich lymphokines.

O'Donnell RW, Marquis DM, Mudholkar GS, McCune CS. O'Donnell RW, et al. Among authors: marquis dm. Cancer Res. 1986 Jul;46(7):3273-8. Cancer Res. 1986. PMID: 3011244 Free article.

4

Anti-beta2 glycoprotein I (beta2GPI) autoantibodies recognize an epitope on the first domain of beta2GPI.

Iverson GM, Victoria EJ, Marquis DM. Iverson GM, et al. Among authors: marquis dm. Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15542-6. doi: 10.1073/pnas.95.26.15542. Proc Natl Acad Sci U S A. 1998. PMID: 9861005 Free PMC article.

5

Use of single point mutations in domain I of beta 2-glycoprotein I to determine fine antigenic specificity of antiphospholipid autoantibodies.

Iverson GM, Reddel S, Victoria EJ, Cockerill KA, Wang YX, Marti-Renom MA, Sali A, Marquis DM, Krilis SA, Linnik MD. Iverson GM, et al. Among authors: marquis dm. J Immunol. 2002 Dec 15;169(12):7097-103. doi: 10.4049/jimmunol.169.12.7097. J Immunol. 2002. PMID: 12471146 Free article.

6

Interleukin 1 as an adjuvant for active specific immunotherapy in a murine tumor model.

McCune CS, Marquis DM. McCune CS, et al. Among authors: marquis dm. Cancer Res. 1990 Feb 15;50(4):1212-5. Cancer Res. 1990. PMID: 2297770 Free article.

7

The L7/L12 stalk, a conserved feature of the prokaryotic ribosome, is attached to the large subunit through its N terminus.

Marquis DM, Fahnestock SR, Henderson E, Woo D, Schwinge S, Clark MW, Lake JA. Marquis DM, et al. J Mol Biol. 1981 Jul 25;150(1):121-32. doi: 10.1016/0022-2836(81)90327-2. J Mol Biol. 1981. PMID: 7028993 No abstract available.

8

Use of a portable ribosome-binding site for maximizing expression of a eukaryotic gene in Escherichia coli.

Marquis DM, Smolec JM, Katz DH. Marquis DM, et al. Gene. 1986;42(2):175-83. doi: 10.1016/0378-1119(86)90294-5. Gene. 1986. PMID: 2426157

9

Renal cell carcinoma treated by vaccines for active specific immunotherapy: correlation of survival with skin testing by autologous tumor cells.

McCune CS, O'Donnell RW, Marquis DM, Sahasrabudhe DM. McCune CS, et al. Among authors: marquis dm. Cancer Immunol Immunother. 1990;32(1):62-6. doi: 10.1007/BF01741726. Cancer Immunol Immunother. 1990. PMID: 2289200 Clinical Trial.

10

Active specific immunotherapy for metastatic colorectal carcinoma: phase I study of an allogeneic cell vaccine plus low-dose interleukin-1 alpha.

Woodlock TJ, Sahasrabudhe DM, Marquis DM, Greene D, Pandya KJ, McCune CS. Woodlock TJ, et al. Among authors: marquis dm. J Immunother. 1999 May;22(3):251-9. doi: 10.1097/00002371-199905000-00008. J Immunother. 1999. PMID: 10335485 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results